Point-of-care testing (POCT) continues to gather momentum and grow at much faster rates than routine clinical laboratory testing. That’s the finding of analysts at Frost & Sullivan. In the United States, POCT product sales totaled $2.1 billion in 2009. Frost & Sullivan predicts that POCT sales will top $3.9 billion by 2016. It says the …
July 12, 2010 “Intelligence: Late Breaking Lab News” Read More »
